España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Alexander Blostein
This Tradeweb Markets Analyst Remains Bullish About Organic Growth, Raises Forecast
Blackstone Exceeds Expectations After Identifying 'The Macro Bottom': Analysts Applaud 'Best Investment Returns In 3 Years'
Blackstone's Performance Could Accelerate In Second Half: Analysts Examine Q1 Results, Outlook
Blackstone Exceeds Expectations After Identifying 'The Macro Bottom': Analysts Applaud 'Best Investment Returns In 3 Years'
Blackstone's Performance Could Accelerate In Second Half: Analysts Examine Q1 Results, Outlook
Charles Schwab Positions For 'More Robust EPS Growth': Analysts Weigh In On Q1 Results
Nasdaq's Road Ahead Marked By Tech Innovation, Market Expansion, And Less Debt: Goldman Sachs
Charles Schwab Positions For 'More Robust EPS Growth': Analysts Weigh In On Q1 Results
|
Nasdaq's Road Ahead Marked By Tech Innovation, Market Expansion, And Less Debt: Goldman Sachs
|
Why Goldman Sachs Says AllianceBernstein Holding Stock Is Underappreciated
|
Why This Raymond James Analyst Sees Upside To $110
|
Read More...
Alexander Blostein Recent News
Goldman Sachs Upgrades State Street, Downgrades UBS And Virtu
|
Goldman Sachs: Bank of New York Mellon Shares Have Modest Upside Potential North Of $60
|
State Street Added To Goldman's Conviction List
|
Analysts See Risks To EPS Upside From CBOE-Bats Deal
|
Goldman Sachs Removes BlackRock From Conviction Buy List
|
Goldman Reviews Q2 Results From BATS Global Markets
|
Goldman Says BATS Is A Niche Growth Story Whose Valuation Leaves Little Upside
|
Intercontinental Exchange Gets Back To Business; Goldman Now Buying The Stock
|
Goldman Sachs Sees 19% Potential Upside In Affiliated Managers Group
|
Goldman Sachs Downgrades Ameriprise Financial, Virtus On 'Weak Flows' And Retail Risks
|
Goldman Sachs Downgrades TD Ameritrade, But Notes 'Lots Of Earnings Per Share Upside'
|
UPDATE: Goldman Sachs Upgrades E Trade, Sees 24% Upside
|
UPDATE: Goldman Sachs Upgrades E*TRADE Financial on Good Upside Potential
|
UPDATE: Goldman Sachs Downgrades NASDAQ OMX Group Amid Rising Margin Risks
|
UPDATE: Goldman Sachs Upgrades TD Ameritrade on Rate Headwinds Starting to Fade
|
UPDATE: Goldman Sachs Upgrades CBOE Holdings on EPS Trajectory
|
UPDATE: Goldman Sachs Upgrades CME Group on Limited Further Upside
|
Goldman Sachs Reiterates Federated Investors (FII) Sell Rating
|